Back to Search
DONOVAN PARKES, MD
MD
Family Medicine Physician
NPI: 1811964133Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
D0034730(MD)
Research & Publications (20)
Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats.
PMID 19543217·Obesity (Silver Spring)·2010
7-preclinical
Exenatide improves hypertension in a rat model of the metabolic syndrome.
PMID 19320558·Metab Syndr Relat Disord·2009
7-preclinical
Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.
PMID 18560368·Int J Obes (Lond)·2008
7-preclinical
Pharmacokinetics and pharmacodynamics of exenatide following alternate routes of administration.
PMID 18291606·Int J Pharm·2008
7-preclinical
Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies.
PMID 18458326·Proc Natl Acad Sci U S A·2008
7-preclinical
Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms.
PMID 18669592·Endocrinology·2008
4-observational
Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight.
PMID 17855496·Am J Physiol Regul Integr Comp Physiol·2007
7-preclinical
Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity.
PMID 17761760·Endocrinology·2007
7-preclinical
Biological activity of AC3174, a peptide analog of exendin-4.
PMID 17292977·Regul Pept·2007
4-observational
Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures.
PMID 16534527·Int J Obes (Lond)·2006
7-preclinical
Biogeochemical value of managed realignment, Humber estuary, UK.
PMID 16996577·Sci Total Environ·2006
8-other
Investigation of exenatide elimination and its in vivo and in vitro degradation.
PMID 16724926·Curr Drug Metab·2006
7-preclinical
Dose-response for inhibition by amylin of cholecystokinin-stimulated secretion of amylase and lipase in rats.
PMID 15982756·Regul Pept·2005
7-preclinical
Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancer.
PMID 16166318·Cancer Res·2005
7-preclinical
Dose-response for glycaemic and metabolic changes 28 days after single injection of long-acting release exenatide in diabetic fatty Zucker rats.
PMID 15915337·Diabetologia·2005
7-preclinical
Exenatide (exendin-4) improves insulin sensitivity and {beta}-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight.
PMID 15618356·Endocrinology·2005
7-preclinical
Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes.
PMID 14700743·Regul Pept·2004
6-review
Effects of PYY[3-36] in rodent models of diabetes and obesity.
PMID 15197409·Int J Obes Relat Metab Disord·2004
7-preclinical
Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
PMID 11319721·Metabolism·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8507 LIBERTY RD, SUITE L1
RANDALLSTOWN, MD 21133 - Phone
- (410) 496-9105
Quick Facts
- NPI
- 1811964133
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile